| Pseudomembrane Removal for Post-RT Nasopharyngeal Necrosis (NCT07552883) | Jiangxi Provincial Cancer Hospital | 2026-04-30 |
| Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma: (NCT07559877) | Jiangxi Provincial Cancer Hospital | 2026-04-01 |
| Limited Target Volume Radiotherapy After Glioblastoma Surgery (NCT07368283) | Jiangxi Provincial Cancer Hospital | 2026-01-01 |
| The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma (NCT07314255) | Jiangxi Provincial Cancer Hospital | 2025-12-18 |
| Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II) (NCT07277764) | Jiangxi Provincial Cancer Hospital | 2025-10-10 |
| Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma (NCT06762470) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma (NCT06770699) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Prognostic Value of TIL in Nasopharyngeal Carcinoma (NCT06763640) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT07085988) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC (NCT06752239) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma (NCT06277050) | Jiangxi Provincial Cancer Hospital | 2024-03-07 |
| Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT06259721) | Jiangxi Provincial Cancer Hospital | 2024-02-10 |
| The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC (NCT06182657) | Jiangxi Provincial Cancer Hospital | 2024-01-01 |
| Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis (NCT05893810) | Jiangxi Provincial Cancer Hospital | 2023-07-01 |
| High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor (NCT05755009) | Jiangxi Provincial Cancer Hospital | 2023-03-01 |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases (NCT05042791) | Jiangxi Provincial Cancer Hospital | 2022-03-01 |
| Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma (NCT05128201) | Jiangxi Provincial Cancer Hospital | 2021-12-01 |
| Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer (NCT05032014) | Jiangxi Provincial Cancer Hospital | 2021-11-19 |
| Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients (NCT05094167) | Jiangxi Provincial Cancer Hospital | 2021-10-19 |
| Thalidomide With or Without Probiotics in Radioactive Oral Mucositis (NCT05059613) | Jiangxi Provincial Cancer Hospital | 2021-09-20 |
| Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy (NCT05032027) | Jiangxi Provincial Cancer Hospital | 2021-08-27 |
| Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma (NCT05177237) | Jiangxi Provincial Cancer Hospital | 2021-07-28 |
| Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC (NCT04557020) | Jiangxi Provincial Cancer Hospital | 2020-12-30 |
| A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast (NCT04481763) | Jiangxi Provincial Cancer Hospital | 2020-07-14 |
| Pathological Classification of Pulmonary Nodules in Images Using Deep Learning (NCT05221814) | Jiangxi Provincial Cancer Hospital | 2020-06-01 |
| 3D Printed Bolus in Post-mastectomy Radiotherapy (NCT04685460) | Jiangxi Provincial Cancer Hospital | 2020-03-01 |
| PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety (NCT06991907) | Jiangxi Provincial Cancer Hospital | 2020-01-01 |
| Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients (NCT06367010) | Jiangxi Provincial Cancer Hospital | 2019-01-01 |
| The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma (NCT06268600) | Jiangxi Provincial Cancer Hospital | 2019-01-01 |
| Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the Treatment of Malignant Tumors (NCT07208487) | Jiangxi Provincial Cancer Hospital | 2019-01-01 |
| Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma (NCT03539250) | Jiangxi Provincial Cancer Hospital | 2018-06-10 |